12/8/2020

Sodium Polystyrene Sulfonate Powder

Products Affected - Description

- Sodium Polystyrene Sulfonate powder for suspension, CMP Pharma, 454 gram, bottle, NDC 46287-0012-16

Reason for the Shortage

- CMP Pharma is not currently producing the powder.
- ECI Pharmaceuticals has sodium polystyrene sulfonate powder available.
- KVK-Tech has sodium polystyrene sulfonate powder available.
- Marlex has sodium polystyrene sulfonate powder available.
- Sunrise Pharmaceuticals has sodium polystyrene sulfonate powder available.
- Trigen has sodium polystyrene sulfonate powder available.

Available Products

- Sodium Polystyrene Sulfonate powder for suspension, ECI Pharmaceuticals, 454 gram, bottle, NDC 51293-0831-97
- Sodium Polystyrene Sulfonate powder for suspension, KVK-Tech, 15 gram, bottle, 12 count, NDC 10702-0036-15
- Sodium Polystyrene Sulfonate powder for suspension, KVK-Tech, 454 gram, bottle, NDC 10702-0036-45
- Sodium Polystyrene Sulfonate powder for suspension, Marlex, 454 gram, bottle, NDC 10135-0146-17
- Sodium Polystyrene Sulfonate powder for suspension, Sunrise, 15 gram, bottle, 10 count, NDC 11534-0166-15
- Sodium Polystyrene Sulfonate powder for suspension, Sunrise, 454 gram, bottle, NDC 11534-0166-44
- Sodium Polystyrene Sulfonate powder for suspension, Trigen, 454 gram, bottle, NDC 13811-0656-53

Estimated Resupply Dates

- All suppliers currently producing the powder have product available.

Updated

Updated December 8, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 22, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.